Reslizumab

Definition: Reslizumab, sold under the brand names Cinqair and Cinqaero, is a humanized monoclonal antibody against human interleukin-5 (IL-5). Reslizumab binds specifically to IL-5, a key cytokine responsible for the differentiation, maturation, recruitment and activation of human eosinophils. By binding to human IL-5, it blocks its biological function; consequently survival and activity of eosinophils are reduced. source: Wikipedia

ID

781215009

Name

Reslizumab

Previous ID

33999711000001105

ID date

6 Feb 2023